INS and systemic lupus erythematosus: Previous studies have suggested that patients with SLE exhibit immune perturbations that predispose to disordered glucose metabolism, including autoantibody-mediated interference with insulin signaling and glucocorticoid-related dysglycemia in susceptible individuals [25–27].